V-BIO Ventures

​V-Bio Ventures has a close working relationship with VIB,  a Belgium-based life sciences institute ranking among the world’s premier institutes, which is also one of the founders of this new dedicated life sciences fund. VIB has a strong reputation in basic and translational life sciences research and an impressive track record in creating successful start-up companies.

V-Bio Ventures invests throughout Europe in start-up and early-stage life science companies with high growth potential. The fund focuses on investments in (bio)pharmaceuticals, diagnostics and agricultural improvements, and intends to build a portfolio of companies drawn from both VIB’s research pipeline and elsewhere.

The first closing was supported by dedicated private and institutional investors, with the European Investment Fund (EIF) as cornerstone investor. The fund is backed by several other investors including ARKimedes, Korys and KU Leuven. ARKimedes is an initiative of ParticipatieMaatschappij Vlaanderen NV and the Region of Flanders.